Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,277 publicly listed stocks with a combined market cap of $1.95 Trillion. Vicore Pharma Holding AB (publ) leads the sector with a market cap of $336.90 Million. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$1.95 Trillion
Companies Listed
1,277
Largest Company
Vicore Pharma Holding …
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 451 |
Vicore Pharma Holding AB (publ)
ST:VICO |
$336.90 Million | Skr3.13 Billion | Sweden | Skr11.12 | +0.91% | -0.54% | 17.74 Million |
| 452 |
Formycon AG
XETRA:FYB |
$336.85 Million | €288.12 Million | Germany | €19.18 | -0.42% | +0.95% | 82.09K |
| 453 |
Abeona Therapeutics Inc
NASDAQ:ABEO |
$335.61 Million | $335.61 Million | USA | $6.42 | -0.77% | +0.63% | 32.61 Million |
| 454 |
Eupraxia Pharmaceuticals Inc
TO:EPRX |
$329.01 Million | CA$454.82 Million | Canada | CA$8.98 | -1.32% | +1.35% | 1.63 Million |
| 455 |
Palisade Bio Inc
NASDAQ:PALI |
$328.93 Million | $328.93 Million | USA | $1.90 | -3.32% | -6.19% | 81.12 Million |
| 456 |
Shandong Sito Bio-technology Co Ltd
SHE:300583 |
$328.67 Million | CN¥2.25 Billion | China | CN¥11.84 | +2.96% | +4.69% | 88.22 Million |
| 457 |
Silence Therapeutics PLC
NASDAQ:SLN |
$326.86 Million | $326.86 Million | USA | $10.49 | -9.72% | -8.38% | 13.57 Million |
| 458 |
CHECKPOINT THER. DL-0001
F:CZTA |
$325.84 Million | €278.71 Million | Germany | €3.76 | +0.00% | +0.00% | 3.33K |
| 459 |
Lexeo Therapeutics, Inc. Common Stock
NASDAQ:LXEO |
$324.29 Million | $324.29 Million | USA | $4.13 | -5.06% | -12.31% | 22.44 Million |
| 460 |
Clinuvel Pharmaceuticals Ltd
AU:CUV |
$323.27 Million | AU$456.88 Million | Australia | AU$9.06 | -2.48% | -8.94% | 2.79 Million |
| 461 |
Jiangsu Bioperfectus Technologies Co Ltd
SHG:688399 |
$321.43 Million | CN¥2.20 Billion | China | CN¥26.19 | +10.09% | -5.93% | 57.28 Million |
| 462 |
Medy-Tox Inc
KQ:086900 |
$321.00 Million | ₩473.67 Billion | Korea | ₩72000.00 | +1.69% | +0.70% | 606.19K |
| 463 |
Avalo Therapeutics Inc
NASDAQ:AVTX |
$318.42 Million | $318.42 Million | USA | $18.25 | -5.88% | +2.76% | 26.88 Million |
| 464 |
Dishman Carbogen Amcis Limited
NSE:DCAL |
$316.97 Million | Rs29.31 Billion | India | Rs186.94 | +0.89% | +4.30% | 8.55 Million |
| 465 |
Zentalis Pharmaceuticals Llc
NASDAQ:ZNTL |
$313.93 Million | $313.93 Million | USA | $4.74 | -3.66% | +6.52% | 30.62 Million |
| 466 |
Jilin Jian Yisheng Pharmaceutical Co Ltd
SHE:002566 |
$313.82 Million | CN¥2.14 Billion | China | CN¥6.48 | -0.61% | +1.25% | 270.35 Million |
| 467 |
Suzhou Fushilai Pharmaceutical Co. Ltd.
SHE:301258 |
$312.69 Million | CN¥2.14 Billion | China | CN¥23.31 | +1.30% | +2.87% | 36.93 Million |
| 468 |
Fennec Pharmaceuticals Inc
NASDAQ:FENC |
$311.94 Million | $311.94 Million | USA | $9.57 | -3.43% | -5.71% | 3.72 Million |
| 469 |
Tanvex BioPharma Inc
TW:6541 |
$311.40 Million | NT$9.88 Billion | Taiwan | NT$37.30 | +1.91% | -6.63% | 9.80 Million |
| 470 |
Tenax Therapeutics Inc
NASDAQ:TENX |
$308.02 Million | $308.02 Million | USA | $13.70 | -9.27% | -6.42% | 33.40 Million |
| 471 |
NEWRON PHARMACEUT. EO-20
XETRA:NP5 |
$306.87 Million | €262.49 Million | Germany | €13.15 | +0.77% | -6.41% | 101.13K |
| 472 |
Keros Therapeutics Inc
NASDAQ:KROS |
$306.79 Million | $306.79 Million | USA | $10.07 | -1.47% | -0.69% | 5.23 Million |
| 473 |
Armata Pharmaceuticals Inc
NYSE MKT:ARMP |
$306.77 Million | $306.77 Million | USA | $8.36 | +1.58% | +1.95% | 1.95 Million |
| 474 |
NEWRON PHARMACEUT. EO-20
F:NP5 |
$306.48 Million | €262.15 Million | Germany | €12.60 | +4.13% | -0.79% | 0.00 |
| 475 |
Scpharmaceuticals Inc
NASDAQ:SCPH |
$304.36 Million | $304.36 Million | USA | $5.67 | +0.00% | +0.35% | 42.79 Million |
| 476 |
Rezolute Inc
NASDAQ:RZLT |
$303.36 Million | $303.36 Million | USA | $4.72 | -3.28% | -11.11% | 37.20 Million |
| 477 |
CLINUVEL PHARMAC.ADRS1
F:UR9A |
$302.25 Million | €258.53 Million | Germany | €5.15 | +0.98% | -2.83% | 924.00 |
| 478 |
Lyell Immunopharma Inc
NASDAQ:LYEL |
$301.87 Million | $301.87 Million | USA | $12.94 | -5.69% | +1.25% | 4.11 Million |
| 479 |
Vanda Pharmaceuticals Inc
NASDAQ:VNDA |
$301.45 Million | $301.45 Million | USA | $5.10 | -1.54% | -4.85% | 19.50 Million |
| 480 |
Cybin Inc
NEO:CYBN |
$301.37 Million | CA$416.62 Million | Canada | CA$8.35 | -27.89% | -22.40% | 402.95K |
| 481 |
Lineage Cell Therapeutics Inc
NYSE MKT:LCTX |
$299.43 Million | $299.43 Million | USA | $1.30 | -1.52% | -0.76% | 31.72 Million |
| 482 |
Newron Pharmaceuticals SpA
SW:NWRN |
$297.11 Million | CHF235.00 Million | Switzerland | CHF11.66 | -1.19% | -1.19% | 1.12 Million |
| 483 |
ANTENGENE CORP. DL-0001
F:722 |
$295.69 Million | €252.92 Million | Germany | €0.41 | +0.98% | -4.61% | 0.00 |
| 484 |
NervGen Pharma Corp
V:NGEN |
$295.10 Million | CA$407.94 Million | Canada | CA$5.15 | +0.00% | -8.20% | 1.13 Million |
| 485 |
OmniAb Inc.
NASDAQ:OABI |
$287.05 Million | $287.05 Million | USA | $1.98 | -0.50% | -2.94% | 10.82 Million |
| 486 |
ABEONA THERAPEUT. DL-01
F:PCJ |
$283.22 Million | €242.25 Million | Germany | €5.31 | +3.23% | -4.46% | 312.00 |
| 487 |
Green Cross
KO:005250 |
$283.20 Million | ₩417.89 Billion | Korea | ₩9300.00 | +2.09% | -3.63% | 1.93 Million |
| 488 |
Crescent Biopharma, Inc.
NASDAQ:CBIO |
$282.17 Million | $282.17 Million | USA | $14.47 | -3.66% | -15.03% | 9.34 Million |
| 489 |
Guiyang Xintian Pharmaceutical Co Ltd
SHE:002873 |
$274.33 Million | CN¥1.87 Billion | China | CN¥7.68 | +2.54% | +3.09% | 202.65 Million |
| 490 |
PharmaEngine
TWO:4162 |
$274.07 Million | NT$8.70 Billion | Taiwan | NT$61.40 | -0.16% | -8.08% | 26.99 Million |
| 491 |
Neumora Therapeutics, Inc.
NASDAQ:NMRA |
$273.60 Million | $273.60 Million | USA | $1.61 | -2.42% | +3.21% | 21.64 Million |
| 492 |
Shanghai Hile Bio-tech
SHG:603718 |
$272.83 Million | CN¥1.86 Billion | China | CN¥2.86 | +4.00% | +6.32% | 160.99 Million |
| 493 |
Niagen Bioscience, Inc.
NASDAQ:NAGE |
$271.34 Million | $271.34 Million | USA | $3.40 | +2.41% | +6.58% | 16.18 Million |
| 494 |
Race Oncology Ltd
AU:RAC |
$270.53 Million | AU$382.33 Million | Australia | AU$1.95 | +1.04% | -4.88% | 2.08 Million |
| 495 |
Immuneering Corp
NASDAQ:IMRX |
$266.67 Million | $266.67 Million | USA | $4.13 | -2.36% | -5.92% | 21.64 Million |
| 496 |
2Seventy Bio Inc
NASDAQ:TSVT |
$266.14 Million | $266.14 Million | USA | $5.00 | +0.00% | +0.00% | 0.00 |
| 497 |
AbClon Inc
KQ:174900 |
$266.01 Million | ₩392.53 Billion | Korea | ₩19700.00 | +14.00% | -5.06% | 2.89 Million |
| 498 |
Foghorn Therapeutics Inc
NASDAQ:FHTX |
$265.37 Million | $265.37 Million | USA | $4.53 | -4.43% | -10.65% | 8.22 Million |
| 499 |
Opus Genetics, Inc.
NASDAQ:IRD |
$264.90 Million | $264.90 Million | USA | $3.71 | -3.39% | +27.05% | 20.58 Million |
| 500 |
Eledon Pharmaceuticals Inc
NASDAQ:ELDN |
$260.89 Million | $260.89 Million | USA | $3.38 | -0.88% | -9.63% | 29.42 Million |
| 501 |
Entrada Therapeutics Inc
NASDAQ:TRDA |
$259.51 Million | $259.51 Million | USA | $6.79 | +0.30% | +12.23% | 10.13 Million |
| 502 |
Inozyme Pharma Inc
NASDAQ:INZY |
$258.25 Million | $258.25 Million | USA | $4.00 | +0.00% | +0.00% | 0.00 |
| 503 |
Surrozen Inc
NASDAQ:SRZN |
$257.87 Million | $257.87 Million | USA | $22.21 | +6.63% | +4.96% | 5.34 Million |
| 504 |
Egetis Therapeutics AB (publ)
ST:EGTX |
$257.03 Million | Skr2.39 Billion | Sweden | Skr6.00 | -1.80% | -9.64% | 12.40 Million |
| 505 |
Tetratherix Ltd
AU:TTX |
$252.81 Million | AU$357.30 Million | Australia | AU$7.45 | +0.68% | +4.93% | 445.05K |
| 506 |
Editas Medicine Inc
NASDAQ:EDIT |
$252.60 Million | $252.60 Million | USA | $2.58 | -4.09% | -5.49% | 48.32 Million |
| 507 |
Jiangsu GDK Biotechnology Co Ltd
SHG:688670 |
$251.13 Million | CN¥1.72 Billion | China | CN¥13.93 | +4.42% | +3.57% | 52.54 Million |
| 508 |
SAB Biotherapeutics Inc
NASDAQ:SABS |
$250.88 Million | $250.88 Million | USA | $3.57 | +0.28% | -0.28% | 12.04 Million |
| 509 |
Sol Gel Technologies Ltd
NASDAQ:SLGL |
$249.62 Million | $249.62 Million | USA | $82.25 | -3.45% | +2.11% | 974.39K |
| 510 |
Turn Therapeutics Inc. Common Stock
NASDAQ:TTRX |
$249.03 Million | $249.03 Million | USA | $8.36 | +1.33% | -11.81% | 2.90 Million |
| 511 |
SILENCE THERAP. SP.ADR/1
F:XRP2 |
$245.62 Million | €210.09 Million | Germany | €7.00 | +10.24% | +40.56% | 5.48K |
| 512 |
Genfit S.A.
NASDAQ:GNFT |
$244.43 Million | $244.43 Million | USA | $5.97 | +0.00% | -3.71% | 49.82K |
| 513 |
Shattuck Labs Inc
NASDAQ:STTK |
$244.26 Million | $244.26 Million | USA | $7.07 | -1.67% | -0.28% | 32.06 Million |
| 514 |
Zura Bio Limited Class A Ordinary Shares
NASDAQ:ZURA |
$243.84 Million | $243.84 Million | USA | $5.43 | -1.99% | +2.65% | 22.38 Million |
| 515 |
Adagene Inc
NASDAQ:ADAG |
$243.81 Million | $243.81 Million | USA | $3.75 | +0.54% | +11.28% | 7.35 Million |
| 516 |
Santhera Pharmaceuticals Holding AG
SW:SANN |
$243.45 Million | CHF192.56 Million | Switzerland | CHF14.16 | -1.94% | -4.07% | 1.45 Million |
| 517 |
Third Harmonic Bio Inc.
NASDAQ:THRD |
$242.79 Million | $242.79 Million | USA | $5.38 | +0.00% | +0.00% | 0.00 |
| 518 |
Orchestra BioMed Holdings Inc.
NASDAQ:OBIO |
$238.33 Million | $238.33 Million | USA | $3.98 | -0.25% | +9.34% | 5.69 Million |
| 519 |
ADAGENE INC. SP.ADR
F:978 |
$237.92 Million | €203.50 Million | Germany | €3.08 | -2.53% | -2.53% | 3.31K |
| 520 |
Fulcrum Therapeutics Inc
NASDAQ:FULC |
$236.17 Million | $236.17 Million | USA | $3.58 | -3.76% | -4.79% | 38.94 Million |
| 521 |
Cybin Inc. Common Stock
NYSE MKT:HELP |
$233.50 Million | $233.50 Million | USA | $4.68 | +1.74% | -7.51% | 27.65 Million |
| 522 |
Anavex Life Sciences Corp
NASDAQ:AVXL |
$231.68 Million | $231.68 Million | USA | $2.75 | +1.85% | +10.89% | 23.00 Million |
| 523 |
Nuvectis Pharma Inc
NASDAQ:NVCT |
$231.56 Million | $231.56 Million | USA | $21.52 | -5.45% | +6.80% | 10.43 Million |
| 524 |
Tiansheng Pharmaceutical Group Co Ltd
SHE:002872 |
$230.34 Million | CN¥1.57 Billion | China | CN¥4.95 | +1.23% | +4.21% | 56.58 Million |
| 525 |
ACELYRIN, INC. Common Stock
NASDAQ:SLRN |
$229.17 Million | $229.17 Million | USA | $2.27 | +0.00% | +0.00% | 0.00 |
| 526 |
Starpharma Holdings Ltd
AU:SPL |
$223.38 Million | AU$315.70 Million | Australia | AU$0.75 | +0.00% | +7.91% | 30.80 Million |
| 527 |
Capricor Therapeutics Inc
NASDAQ:CAPR |
$222.96 Million | $222.96 Million | USA | $3.85 | -8.11% | -80.58% | 114.15 Million |
| 528 |
AC Immune Ltd
NASDAQ:ACIU |
$222.88 Million | $222.88 Million | USA | $2.19 | -7.59% | -2.23% | 5.70 Million |
| 529 |
Protara Therapeutics Inc
NASDAQ:TARA |
$220.32 Million | $220.32 Million | USA | $3.92 | -2.73% | -2.97% | 14.76 Million |
| 530 |
Adimmune Corp
TW:4142 |
$219.78 Million | NT$6.98 Billion | Taiwan | NT$16.55 | +0.00% | -2.93% | 29.56 Million |
| 531 |
ProKidney Corp.
NASDAQ:PROK |
$218.66 Million | $218.66 Million | USA | $1.54 | -2.53% | +1.32% | 29.52 Million |
| 532 |
MacroGenics Inc
NASDAQ:MGNX |
$218.65 Million | $218.65 Million | USA | $3.69 | -2.38% | -7.98% | 20.28 Million |
| 533 |
AC IMMUNE SA SF-02
F:IMR |
$217.80 Million | €186.29 Million | Germany | €1.99 | +4.30% | +4.63% | 2.00K |
| 534 |
CARGO Therapeutics, Inc. Common Stock
NASDAQ:CRGX |
$216.19 Million | $216.19 Million | USA | $4.47 | +0.00% | +0.22% | 22.76 Million |
| 535 |
Thor Medical ASA
OL:TRMED |
$215.82 Million | Nkr2.05 Billion | Norway | Nkr5.79 | +28.10% | +30.70% | 34.89 Million |
| 536 |
Oryzon Genomics SA
MC:ORY |
$214.95 Million | €183.86 Million | Spain | €2.88 | -0.14% | -3.23% | 11.61 Million |
| 537 |
Saniona AB
ST:SANION |
$211.38 Million | Skr1.96 Billion | Sweden | Skr14.23 | +1.79% | +8.21% | 7.34 Million |
| 538 |
Coherus BioSciences Inc
NASDAQ:CHRS |
$211.34 Million | $211.34 Million | USA | $1.41 | -4.08% | -1.40% | 17.01 Million |
| 539 |
Cellectis
PA:ALCLS |
$209.45 Million | €179.15 Million | France | €2.47 | -1.59% | +0.24% | 3.83 Million |
| 540 |
Transgene SA
PA:TNG |
$208.69 Million | €178.51 Million | France | €0.71 | -0.28% | -1.66% | 808.27K |
| 541 |
Satellos Bioscience Inc.
TO:MSCL |
$208.31 Million | CA$287.97 Million | Canada | CA$14.00 | +5.11% | +2.26% | 975.50K |
| 542 |
Alx Oncology Holdings
NASDAQ:ALXO |
$207.23 Million | $207.23 Million | USA | $1.94 | -0.51% | -3.96% | 21.74 Million |
| 543 |
Circio Holding ASA
OL:CRNA |
$205.25 Million | Nkr1.95 Billion | Norway | Nkr8.20 | -3.07% | -7.87% | 89.02 Million |
| 544 |
Atrys Health SL
MC:ATRY |
$202.32 Million | €173.06 Million | Spain | €2.60 | -1.70% | +6.12% | 1.48 Million |
| 545 |
GENFIT S.A. ADR/1 EO-25
F:XUPB |
$200.59 Million | €171.58 Million | Germany | €5.90 | -4.07% | +9.26% | 252.00 |
| 546 |
Cellectis SA
NASDAQ:CLLS |
$199.92 Million | $199.92 Million | USA | $2.75 | -3.51% | -0.72% | 368.83K |
| 547 |
Greenwich Lifesciences Inc
NASDAQ:GLSI |
$198.16 Million | $198.16 Million | USA | $13.50 | -3.71% | +2.35% | 4.13 Million |
| 548 |
Bicycle Therapeutics plc
F:50BA |
$196.70 Million | €168.25 Million | Germany | €3.34 | +1.83% | -5.65% | 0.00 |
| 549 |
SillaJen Inc
KQ:215600 |
$193.77 Million | ₩285.93 Billion | Korea | ₩2070.00 | +6.87% | -0.48% | 12.20 Million |
| 550 |
Bicycle Therapeutics Ltd
NASDAQ:BCYC |
$192.73 Million | $192.73 Million | USA | $3.86 | -3.74% | -7.21% | 8.79 Million |
| 551 |
ONWARD MEDICAL BV EO -12
F:63E |
$191.02 Million | €163.39 Million | Germany | €2.35 | -0.21% | -5.05% | 0.00 |
| 552 |
Sinphar Pharmaceutical Co Ltd
TW:1734 |
$189.95 Million | NT$6.03 Billion | Taiwan | NT$31.70 | +0.00% | +6.71% | 11.83 Million |
| 553 |
Onward Medical N.V.
BR:ONWD |
$189.40 Million | €162.00 Million | Belgium | €2.33 | -2.10% | -3.12% | 1.92 Million |
| 554 |
SOL-GEL TECHN. IS-10
F:4SG |
$188.23 Million | €161.00 Million | Germany | €60.00 | -4.00% | -5.51% | 1.36K |
| 555 |
I-MAB SPONS.ADS/1 -0001
F:0VY |
$186.58 Million | €159.59 Million | Germany | €1.38 | -8.61% | -10.97% | 0.00 |
| 556 |
Minerva Neurosciences Inc
NASDAQ:NERV |
$185.42 Million | $185.42 Million | USA | $3.98 | -1.00% | -10.56% | 4.44 Million |
| 557 |
Genomictree Inc.
KQ:228760 |
$184.57 Million | ₩272.35 Billion | Korea | ₩11340.00 | +9.78% | -7.73% | 2.48 Million |
| 558 |
NovaBridge Biosciences
NASDAQ:NBP |
$184.47 Million | $184.47 Million | USA | $1.60 | -2.44% | -9.60% | 15.21 Million |
| 559 |
Taigen Biopharmaceuticals Holdings Ltd
TWO:4157 |
$182.33 Million | NT$5.79 Billion | Taiwan | NT$8.13 | +2.91% | -4.13% | 23.67 Million |
| 560 |
Mediwound Ltd
NASDAQ:MDWD |
$181.23 Million | $181.23 Million | USA | $14.12 | +0.14% | -1.05% | 1.76 Million |
| 561 |
Precision BioSciences Inc
NASDAQ:DTIL |
$180.36 Million | $180.36 Million | USA | $6.99 | -0.14% | -4.64% | 11.24 Million |
| 562 |
CAMP4 THERAPEUTICS CORPORATION
NASDAQ:CAMP |
$179.14 Million | $179.14 Million | USA | $3.45 | -0.58% | +14.62% | 4.22 Million |
| 563 |
Cabio Biotech Wuhan Co Ltd
SHG:688089 |
$177.57 Million | CN¥1.21 Billion | China | CN¥7.21 | +3.30% | -28.33% | 96.67 Million |
| 564 |
Atrium Therapeutics, Inc. Common Stock
NASDAQ:RNA |
$176.09 Million | $176.09 Million | USA | $11.35 | -0.96% | -4.70% | 4.24 Million |
| 565 |
MediWound Ltd
F:M8W |
$176.08 Million | €150.61 Million | Germany | €12.00 | -2.44% | -3.23% | 0.00 |
| 566 |
Compugen
TA:CGEN |
$172.65 Million | ILA64.40 Billion | Israel | ILA688.50 | -0.38% | -2.28% | 608.22K |
| 567 |
NervGen Pharma Corp.
NASDAQ:NGEN |
$172.39 Million | $172.39 Million | USA | $1.62 | +1.25% | -3.28% | 17.08 Million |
| 568 |
Cartesian Therapeutics Inc.
NASDAQ:RNAC |
$172.18 Million | $172.18 Million | USA | $7.80 | +0.91% | -1.52% | 3.78 Million |
| 569 |
Forte Biosciences Inc
NASDAQ:FBRX |
$172.07 Million | $172.07 Million | USA | $76.60 | -0.49% | +28.31% | 48.26 Million |
| 570 |
Galectin Therapeutics Inc
NASDAQ:GALT |
$171.89 Million | $171.89 Million | USA | $2.97 | -8.05% | -13.91% | 15.03 Million |
| 571 |
SANIONA AB (PUBL)
F:30S |
$170.61 Million | €145.93 Million | Germany | €1.23 | +3.88% | +7.41% | 0.00 |
| 572 |
Voyager Therapeutics Inc
NASDAQ:VYGR |
$168.47 Million | $168.47 Million | USA | $3.03 | -3.19% | -1.94% | 17.09 Million |
| 573 |
Alector Inc
NASDAQ:ALEC |
$166.65 Million | $166.65 Million | USA | $1.51 | -6.79% | +1.34% | 12.10 Million |
| 574 |
Sensorion SA
PA:ALSEN |
$166.23 Million | €142.18 Million | France | €0.28 | +2.53% | +6.17% | 24.12 Million |
| 575 |
LENZ Therapeutics Inc
NASDAQ:LENZ |
$166.18 Million | $166.18 Million | USA | $5.30 | -7.99% | +4.95% | 24.88 Million |
| 576 |
Savior Lifetec
TWO:4167 |
$165.29 Million | NT$5.25 Billion | Taiwan | NT$16.90 | +1.20% | -17.96% | 33.76 Million |
| 577 |
Molecular Partners AG ADR
NASDAQ:MOLN |
$164.56 Million | $164.56 Million | USA | $4.40 | +1.38% | +4.76% | 66.47K |
| 578 |
GeneOne Life Science Inc
KO:011000 |
$164.07 Million | ₩242.10 Billion | Korea | ₩2670.00 | +400.00% | +201.69% | 120.17 Million |
| 579 |
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT |
$163.72 Million | $163.72 Million | USA | $5.76 | -2.70% | -0.52% | 12.62 Million |
| 580 |
BioInvent International AB
ST:BINV |
$162.52 Million | Skr1.51 Billion | Sweden | Skr22.95 | -1.08% | +3.38% | 1.52 Million |
| 581 |
Bioversys AG
SW:BIOV |
$161.41 Million | CHF127.67 Million | Switzerland | CHF26.60 | -2.92% | -2.92% | 23.49K |
| 582 |
AN2 Therapeutics Inc
NASDAQ:ANTX |
$160.54 Million | $160.54 Million | USA | $5.35 | +0.38% | +8.74% | 5.04 Million |
| 583 |
Satellos Bioscience Inc. Common Stock
NASDAQ:MSLE |
$160.19 Million | $160.19 Million | USA | $9.99 | +3.42% | +3.85% | 2.25 Million |
| 584 |
Immunic Inc
NASDAQ:IMUX |
$158.42 Million | $158.42 Million | USA | $13.97 | -0.14% | -2.17% | 3.60 Million |
| 585 |
Panion & BF Biotech Inc
TW:1760 |
$158.29 Million | NT$5.02 Billion | Taiwan | NT$58.60 | +1.03% | -4.09% | 6.34 Million |
| 586 |
Mycenax Biotech
TWO:4726 |
$158.05 Million | NT$5.02 Billion | Taiwan | NT$24.20 | +0.21% | -2.02% | 4.19 Million |
| 587 |
Invivyd Inc.
NASDAQ:IVVD |
$157.61 Million | $157.61 Million | USA | $0.54 | -8.01% | -12.18% | 79.69 Million |
| 588 |
Jyong Biotech Ltd. Ordinary Shares
NASDAQ:MENS |
$157.38 Million | $157.38 Million | USA | $2.15 | -3.59% | -20.66% | 1.74 Million |
| 589 |
Hyloris Developmentsen Sa
BR:HYL |
$156.48 Million | €133.84 Million | Belgium | €4.78 | -0.21% | +1.70% | 63.95K |
| 590 |
Protalix Biotherapeutics Inc
NYSE MKT:PLX |
$156.31 Million | $156.31 Million | USA | $2.10 | +3.45% | +5.00% | 19.50 Million |
| 591 |
Acumen Pharmaceuticals Inc
NASDAQ:ABOS |
$155.29 Million | $155.29 Million | USA | $2.15 | -0.92% | -0.92% | 9.54 Million |
| 592 |
ProQR Therapeutics BV
NASDAQ:PRQR |
$153.80 Million | $153.80 Million | USA | $1.72 | -3.37% | -3.91% | 26.79 Million |
| 593 |
Korro Bio, Inc.
NASDAQ:KRRO |
$149.56 Million | $149.56 Million | USA | $10.37 | -0.77% | -10.06% | 4.53 Million |
| 594 |
Nkarta Inc
NASDAQ:NKTX |
$149.53 Million | $149.53 Million | USA | $2.09 | -2.79% | -9.13% | 18.54 Million |
| 595 |
Oramed Pharmaceuticals Inc
NASDAQ:ORMP |
$149.38 Million | $149.38 Million | USA | $4.07 | -1.21% | -2.16% | 5.70 Million |
| 596 |
Canton Strategic Holdings, Inc.
NASDAQ:CNTN |
$148.85 Million | $148.85 Million | USA | $1.93 | +4.32% | -6.31% | 18.11 Million |
| 597 |
Theratechnologies Inc.
TO:TH |
$148.68 Million | CA$205.53 Million | Canada | CA$4.47 | -4.89% | -1.76% | 547.73K |
| 598 |
Biomm S.A
SA:BIOM3 |
$147.95 Million | R$754.00 Million | Brazil | R$5.51 | -4.84% | -10.84% | 1.28 Million |
| 599 |
Molecular Partners AG
SW:MOLN |
$145.86 Million | CHF115.37 Million | Switzerland | CHF3.33 | -0.30% | +3.10% | 388.44K |
| 600 |
Mersana Therapeutics Inc
NASDAQ:MRSN |
$145.36 Million | $145.36 Million | USA | $29.08 | +0.14% | -0.07% | 2.50 Million |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries